About Jian Han

Jian Han, MD, PhD

Technology development to advance medical science

Faculty Investigator

Email: jhan@hudsonalpha.org
Phone: 256-327-0022
Location: 601 Genome Way, Huntsville, AL 35806

For Jian Han, MD, PhD, the immune system holds the key to unlocking disease diagnosis.

Han is a faculty investigator at HudsonAlpha Institute for Biotechnology where he develops new methods for diagnosing disease by looking at tiny molecular changes, speeding up the time it takes for a physician to diagnose a microbial infection, for instance.  He also maps the personalized immunorepertoire, the body’s immune response to an external attacks.

“Our immune system knows best when it comes to diagnosing and treating a disease,” he says. “It’s more sensitive than any test we could invent.”

Han earned his MD from ShuZhou Medical College, ShuZhou, China, in 1983 and his PhD from the University of Alabama at Birmingham in 1991. He founded Genaco Biomedical Products in 1996 and led the company as its CEO until 2003 and its CSO until 2007. He joined HudsonAlpha in 2007 and founded two associate companies, iCubate and iRepertoire, in 2009.

At HudsonAlpha, Han runs the Repertoire 10,000 (R10K) project, which analyzes the immune signatures of diseases related to autoimmunity, inflammation, cancer and infectious disease. Because individual immune systems could respond similarly to a particular disease, the project is looking for a common immune system imprint, visually represented in colorful images, that could be used to recognize disease. The goal of the project is to develop a simple, low-cost and accurate method for disease diagnosis and monitoring.

“Developing these tools to help scientists better understand diseases,” Han says, “and to be the first to look at the data and solve a puzzle is extremely rewarding.”

Recent News

September 27, 2017
Huntsville, Ala. ━ Leading researchers from around the world will convene at HudsonAlpha Institute for Biotechnology on Oct. 2-4, 2017 for the fifth annual Immunogenomics conference. Immunogenomics lies at the intersection of im...
August 22, 2017
iCubate’s platform and initial assay now available for European clinical laboratory use Huntsville, Ala. August 22, 2017 – iCubate, Inc., an innovative molecular diagnostic device company, announced today that it has received ...
August 10, 2017
Huntsville, Ala. – iCubate®, Inc., an innovative molecular diagnostic device company located on the HudsonAlpha Institute for Biotechnology campus, announced today that it has earned U.S. Food and Drug Administration (FDA) clea...
Load More


Color Skin